Drug stocks diverge; Medicines Co. tanks

BOSTON (MarketWatch) -- Drug stocks diverged in early trading Wednesday, while shares of The Medicines Company tanked on news that it was discontinuing a key Phase III testing program for its new blood-thinner due to poor results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.